SARCOMAS

Clinical trials for SARCOMAS explained in plain language.

Never miss a new study

Get alerted when new SARCOMAS trials appear

Sign up with your email to follow new studies for SARCOMAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet recruiting 2 Not yet finished but already full! 1

New pill targets cancer's genetic weak spot in 15 tumor types

Disease control Ongoing

This study tests a drug called entrectinib in people with advanced cancers that have certain gene changes (NTRK, ROS1, or ALK). About 534 adults with 15 different cancer types will take the pill daily. The goal is to see if the drug shrinks tumors and how long that effect lasts.

Matched conditions: SARCOMAS

Phase: PHASE2 • Sponsor: Hoffmann-La Roche • Aim: Disease control

Last updated Jun 12, 2026 12:05 UTC

SARCOMAS

Get alerted when new SARCOMAS trials appear

New pill targets cancer's genetic weak spot in 15 tumor types